Work

Lecanemab in early Alzheimer’s disease: extended efficacy results from the CLARITY AD study

Year: 2024

Type: conference-paper

DOI: 10.1136/jnnp-2024-abn.138

Authors: Sperling Reisa, Li David, Dhadda Shobha, Hersch Steven, Reyderman Larisa, Irizarry Michael, McMurray Rob, Warner Michael, Kramer Lynn

Institutions: Harvard University, Eisai (United States), Barrow Neurological Institute, Eisai (United Kingdom)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404183124

FWCI: 6.127

Cites:

Cited by: 2

Related to: 10